26
|
Maggiolo F, Airoldi M, Kleinloog HD, Callegaro A, Ravasio V, Arici C, Bombana E, Suter F. Effect of Adherence to HAART on Virologic Outcome and on the Selection of Resistance-Conferring Mutations in NNRTI- or PI-Treated Patients. HIV CLINICAL TRIALS 2015; 8:282-92. [DOI: 10.1310/hct0805-282] [Citation(s) in RCA: 115] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
27
|
Ostellino O, Garzaro M, Pedani F, Airoldi M, Bellini E, Raimondo L, Pecorari G. Cisplatin + Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (Rmsgm): a Final Report on 60 Cases. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu340.44] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
Tonini G, Mouysset J, Rotarski M, Spaeth D, Airoldi M, Toganel C, Christofyllakis C, Belton L, Bohac C, Terwey J. Additional Haemoglobin (Hb) and Quality of Life (Qol) Analyses from Eaqua. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu356.30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Bossi P, Russi E, Numico G, De Sanctis V, Denaro N, Ghi M, Mirabile A, Moretto F, Ripamonti C, Buglione M, Airoldi M, Vermorken J, Murphy B, Langendijk J, Raber Durlacher J, Licitra L. Defining Best Practices on Supportive Care During Chemo-Radiotherapy for Head and Neck Cancer with a Formal Systematic Methodology. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu340.6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
Merlini L, Carteni G, Iacobelli S, Stelitano C, Airoldi M, Balke P, Keil F, Haslbauer F, Belton L, Pujol B. Anemia Point Prevalence in Patients Receiving Chemotherapy in 56 Centers in Italy and Austria. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)34179-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
31
|
Ostellino O, Airoldi M, Garzaro M, Pedani F, Raimondo L, Riva G, Carnio S, Pecorari G, Fora G, Giordano C. Cisplatin + Vinorelbine (DDP + VNB) Administered in 60 Cases of Recurrent/Metastatic Salivary Gland Malignancies (RMSGM): Final Report. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33616-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
32
|
Tironi M, Tremolizzo L, Stefanoni G, Airoldi M, Motta E, Patassini M, Canonico F, Ferrarese C, Appollonio I. Back to the ring: knocking-out headache. Neurol Sci 2011; 33:941-3. [PMID: 22124852 DOI: 10.1007/s10072-011-0858-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2011] [Accepted: 11/10/2011] [Indexed: 10/15/2022]
|
33
|
Airoldi M, Garzaro M, Raimondo L, Riva G, Ostellino O, Pecorari G, Giordano C. 8592 POSTER Long Term Quality of Life, Physical and Psychological Functioning in Patients Affected by Relapsed Head and Neck Cancer. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)72234-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
34
|
Garzaro M, Raimondo L, Pecorari G, Pedani F, Giordano C, Airoldi M. Comparison of two schedules in locally advanced nasopharyngeal carcinoma observed in a nonendemic population. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.5542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
35
|
Raimondo L, Garzaro M, Riva G, Pecorari G, Giordano C, Airoldi M. Long-term toxicity: A comparison between surgery plus radiotherapy and exclusive chemoradiation therapy regimes in oropharyngeal cancer patients. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.5535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
36
|
Airoldi M, Garzaro M, Raimondo L, Riva G, Pecorari G, Giordano C. Quality of life, physical, and psychologic functioning in patients affected by end-stage head and neck cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.5537] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
37
|
Soria A, Airoldi M, Migliorino G, Squillace N, Bandera A, Lapadula G, Gori A. Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: relapse or late IRIS? J Antimicrob Chemother 2011; 66:1190-1. [DOI: 10.1093/jac/dkr067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Riebe B, Karas CS, Bagan B, Baig MN, Hallock A, Hamilton B, Ang CL, Tay K, Megyesi J, Fisher B, Watling C, MacDonald D, Bauman G, Momin E, Adams H, Quinones-Hinojosa A, Ruda R, Bertero L, Picco E, Trevian E, Tarenzi L, Donadio M, Airoldi M, Bertetto O, Mocellini C, Soffietti R, McCarthy BJ, Dolecek TA, Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, Folsom AR, Virnig BA, Cerhan JR, Scheurer ME, Etzel CJ, Wefel JS, Liu Y, Liang FW, El-Zein R, Meyers CA, Bondy ML, Davis F, Dolecek TA, McCarthy BJ, Hottinger AF, Perez L, Usel M, Neyroud-Caspar I, Bouchardy C, Dietrich PY, Jho DJ, Eltantawy MH, Sekula R, Aziz K, Lee SY, Slagle-Webb B, Sheehan JM, Connor JR, Elena P, Andrew L, Anne R, Katherine P, Lisa D, Lai RK, Ferris J, Florendo E, McCoy L, Rice T, Ottman R, Neugut AI, Wiencke J, Wiemels J, Wrensch M, Yovino S, Hadley C, Kwok Y, Eisenberg H, Regine WF, Feigenberg S, Megyesi JF, Haji F, Patel Y, Ang LC, Lachance DH, Wrensch M, Il'yasova D, Decker P, Johnson D, Xiao Y, Rynearson A, Fink S, Kosel M, Yang P, Fridley B, Wiemels J, Wiencke J, Ali-Osman F, Davis F, Kollmeyer T, Buckner J, O'Neill B, Jenkins R. Epidemiology. Neuro Oncol 2010. [DOI: 10.1093/neuonc/noq116.s3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Bandera A, Ferrario G, Saresella M, Marventano I, Soria A, Zanini F, Sabbatini F, Airoldi M, Marchetti G, Franzetti F, Trabattoni D, Clerici M, Gori A. CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS One 2010; 5:e10788. [PMID: 20520721 PMCID: PMC2875388 DOI: 10.1371/journal.pone.0010788] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2010] [Accepted: 04/19/2010] [Indexed: 01/06/2023] Open
Abstract
Mechanisms by which HIV affects the thymus are multiple and only partially known, and the role of thymic dysfunction in HIV/AIDS immunopathogenesis remains poorly understood. To evaluate the effects of HIV infection on intra-thymic precursors of T cells in HIV-infected adults, we conducted a detailed immunophenotypic study of thymic tissue isolated from 7 HIV-infected and 10 HIV-negative adults who were to undergo heart surgery. We found that thymuses of HIV-infected individuals were characterized by a relative depletion of CD4+ single positive T cells and a corresponding enrichment of CD8+ single positive T cells. In addition, thymocytes derived from HIV-infected subjects showed increased levels of activated and proliferating cells. Our analysis also revealed a decreased expression of interleukin-7 receptor in early thymocytes from HIV-infected individuals, along with an increase in this same expression in mature double- and single-positive cells. Frequency of regulatory T cells (CD25+FoxP3+) was significantly increased in HIV-infected thymuses, particularly in priorly-committed CD4 single positive cells. Our data suggest that HIV infection is associated with a complex set of changes in the immunophenotype of thymocytes, including a reduction of intrathymic CD4+ T cell precursors, increased expression of activation markers, changes in the expression pattern of IL-7R and enrichment of T regulatory cells generation.
Collapse
|
40
|
Airoldi M, Garzaro M, Raimondo L, Pecorari G, Giordano C. A comparison between surgery plus radiotherapy and exclusive chemoradiation therapy regimes in oral and oropharyngeal cancer: Long-term functional and psychological impact. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
41
|
Numico G, Airoldi M, Gabriele P, Gabriele A, Garzaro M, Raimondo L, Pedani F, Beatrice F, Pecorari G, Giordano C. Induction chemotherapy with carboplatin and paclitaxel followed by radiotherapy and concurrent weekly carboplatin plus paclitaxel in locally advanced nasopharyngeal carcinoma in a nonendemic population. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5569] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
42
|
Rudà R, Bertero L, Picco E, Trevisan E, Tarenzi L, Donadio M, Airoldi M, Bertetto O, Mocellini C, Soffietti R. Frequency, patterns of care, and outcome of neoplastic meningitis (NM) from solid tumors in regione Piemonte, Italy: A prospective survey from a cancer network. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e12530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
43
|
Airoldi M, Zaccarelli M, Bisi L, Bini T, Antinori A, Mussini C, Bai F, Orofino G, Sighinolfi L, Gori A, Suter F, Maggiolo F. One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence 2010; 4:115-25. [PMID: 20517472 PMCID: PMC2875721 DOI: 10.2147/ppa.s10330] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2010] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVE The aim of the ADONE (ADherence to ONE pill) study was to verify the effect of a reduced number of pills on adherence and quality of life (QoL) in HIV-infected patients on highly active antiretroviral therapy (HAART). DESIGN Prospective, multicenter, study. METHODS Patients chronically treated with emtricitabine (FTC) + tenofovir (TDF) + efavirenz (EFV) or lamivudine (3TC) +TDF +EFV and with a HIV-RNA < 50 copies/mL were switched to the single-pill fixed-dose regimen (FDR) of FTC +TDF +EFV. Data were collected with SF-36 using visual analog scales. Results of the final (6 months) primary as-treated analysis are reported. RESULTS 212 patients (77.4% males) of mean age 45.8 years were enrolled; 202 completed the study. One month post switch to FDR the adherence rate increased significantly to 96.1% from a baseline value of 93.8% (P < 0.01). The increase was steadily maintained throughout the study (96.2% at 6 months). QoL improved over time from 68.8% to 72.7% (P = 0.042) as well, and was significantly associated with the perception of health status, presence of adverse events (AEs) and number of reported AEs (P < 0.0001). QoL significantly influenced adherence (P < 0.0001). During FDR use the mean CD4 count increased from 556 to 605 cells/muL (P < 0.0001). At the end of follow-up 98% of patients maintained HIV-RNA level < 50 copies/mL and 100% <400 copies/mL. Four patients stopped therapy because they were lost to follow-up and 6 because of AEs (insomnia/nervousness 4, allergy 1, difficulties swallowing pills 1). CONCLUSION By substituting a one-pill once-a-day HAART, we observed an improvement of both adherence and QoL while maintaining high virologic and immunologic efficacy. HAART simplicity is an added value that favors adherence and may improve long-term success.
Collapse
|
44
|
Maggiolo F, Roat E, Pinti M, Nasi M, Gibellini L, De Biasi S, Airoldi M, Ravasio V, Mussini C, Suter F, Cossarizza A. Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients. Antivir Ther 2010; 15:51-9. [DOI: 10.3851/imp1483] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
45
|
Gabriele A, Airoldi M, Garzaro M, Raimondo L, Pedani F, Beatrice F, Pecorari G, Giordano C. 8556 Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71647-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
46
|
Airoldi M, Garzaro M, Raimondo L, Gabriele A, Giordano C. 8555 Induction chemotherapy with cysplatin and epirubicin followed by radiotherapy and concurrent cysplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71646-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
47
|
Raimondo L, Airoldi M, Garzaro M, Pecorari G, Caldera P, Varetto A, Torta R, Giordano C. 8569 Neoadjuvant chemotherapy plus concomitant chemoradiotherapy in head and neck cancer: late toxicity and impact on quality of life. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71660-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
48
|
Zanon C, Airoldi M, Garzaro M, Raimondo L. Functional and psychological evaluation after exclusive chemoradiation therapy in oral and oropharyngeal cancer. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e17012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e17012 Purpose: The treatment of head and neck tumours often negatively affects speech, swallowing, body image and quality of life (QoL). Aim of this study was the evaluation of the impact of exclusive chemoradiation therapy (CH-RT) on QoL and psychological functioning. Patients and Methods: Twenty-eight patients, affected by a carcinoma of the oral cavity and oropharynx received exclusive CH-RT. Late effects of CH-RT and psycho-oncological assessment included: Radiation Therapy Oncology Group (RTOG) - European Organisation for Research and Treatment of Cancer (EORTC) late radiation morbidity scoring system, DISCHE morbidity recording scheme, Hospital Anxiety and Depression Scale (HADS), Montgomery Asberg Depression Rating Scale (MADRS), Mini Mental Adjustment to Cancer (MINI MAC), and EORTC QoL Head and Neck 35. Results: After a median follow-up of 42 months (range 12–60 months) moderate-severe late toxicity was as follows: taste impairment (89.20%), salivary function (82.12%), subcutaneous tissue (7.08%). Concerning dysphagia 39% of patients complained some discomfort, 28% had a more severe toxicity whereas 7% could not have an oral feeding; patients with severe dysphagia showed higher levels of anxiety (p < 0.05): dysphagia influences the QoL, fatigue and physical-social functioning. Rates of depression and anxiety were generally low: 78.6% of our sample did not show clinical relevant anxious symptoms and 82.1% of patients did not reach the threshold of an overt depression. Just a fair concordance in rate of depression between self- and hetero-evaluated scale was observed, with higher rates relieved by MADRS compare to HADS depression subscale using 8 or 10 cut-off (Cohen's k test = 0.401) Conclusions: Our data suggest low rates of anxiety and depression, in patients treated with CH-RT, with a different evaluation between self-evaluative and hetero-evaluative scales. No significant financial relationships to disclose.
Collapse
|
49
|
Airoldi M, Garzaro M, Gabriele A, Raimondo L. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a nonendemic population. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e17040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e17040 Background: Chemoradiotherapy (CRT) represents the main therapy choice in the treatment of locoregionally advanced nasopharyngeal carcinoma (NPC). Aim of this study was the clinical evaluation of neoadjuvant chemotherapy (NACT) followed by CRT in a non endemic population affected by advanced NPC. Methods: Patients with locoregionally advanced NPC were treated with three cycles of induction chemotherapy (CHT) with cisplatin (100 mg/m2) plus epirubicin (90 mg/m2), followed by cisplatin (100 mg/m2) and concomitant radiotherapy (70 Gy). Results: In 40 patients treated with such protocol, after the completion of induction CHT and CRT we observed the objective response rates of 90% and 100% respectively. Treatment tolerability and toxicity were easily controllable. With a median follow-up time of 54.5 months 3- and 5-years disease-free survival was 75% and 65.4% and 3- and 5-years overall survival was 84% and 77.5%. 3- and 5-years loco-regional control was 82.4% and 70.3%, and 5-years distant metastases-free survival was 75%. Conclusions: NACT with cisplatin and epirubicin followed by concomitant CRT represents a feasible, efficient treatment for patients with advanced NPC. This regimen ensures an excellent locoregional disease control and overall survival with a low incidence of distant metastases. No significant financial relationships to disclose.
Collapse
|
50
|
Garzaro M, Airoldi M, Raimondo L, Pecorari G, Giordano C, Caldera P, Varetto A, Zanon C, Torta R. Long-term quality of life and psychological response after flap reconstructive surgery and radiotherapy in head and neck cancer patients. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.20553] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|